On October 17-21.

The Company will also be hosting an EACTS Satellite Symposium on October 19th entitled, Frontiers In Cryoablation: Cryosurgery for the Treatment of Cardiac Arrhythmia and moderated by Friedrich Mohr, MD, PhD, from the University of Leipzig Heart Center. The Symposium will focus on the newest approaches for completing the Cox CryoMaze III lesion set in concomitant and stand-alone methods. Eva Berglin, MD, PhD, from Sahlgrenska University, Gothenberg, Sweden, on October 19th during a presentation entitled will address attendees at the ATS exhibition booth, The Concomitant CryoMaze Procedure; the Sahlgrenska Encounter. Niv Ad, MD, from Fairfax Hospital in Falls Church, Virginia, will show The Surgical Treatment of Atrial Fibrillation: Minimally Invasive CryoMaze III Without Aortic Cross Clamp on October 20th.Results Characteristics of the Patients From 2004 through 2011, the outbreak strain was isolated from 316 case individuals, as reported by the departments of wellness in 43 states . The number of cases peaked in the spring annually; the ideal number of instances was reported in 2006 . Age and sex had been reported for 266 and 280 patients, respectively. The median age group of patients was 4 years , and 143 were 5 years or younger ; 149 patients were feminine. Interviews were finished with 156 of the 316 individuals ; 153 reported diarrhea, and among the 145 patients with available details, 80 reported bloody diarrhea. Thirty-six of the 156 patients interviewed had been hospitalized for a median duration of 2 days .